Benzinga74d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose TrackingNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Insider Monkey76d agoneutral
Abbott Pays $670 Million to Settle Formula Claims as Legal Risks PersistInsider Monkey77d agoneutral
Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside?Simply Wall St.77d agoneutral
How Investors Are Reacting To Abbott Laboratories (ABT) US$670 Million NEC Settlement And Litigation ClarityInsider Monkey77d agoneutral
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?Simply Wall St.77d agoneutral
Abbott Laboratories (ABT) Could Be 2% Undervalued After Its Formula SettlementMotley Fool77d agobullish
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?Benzinga79d agoneutral
Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula LitigationInsider Monkey80d agoneutral
Can Abbott Laboratories (ABT)’s Instinct Sensor Give MiniMed Group (MMED) a Competitive Edge?The Wall Street Journal80d agoneutral
Abbott to Pay $670 Million to Settle Baby-Formula LitigationInsider Monkey81d agoneutral
Abbott vs. Intuitive Surgical: Is Consistent Growth Better Than Premium Growth?Simply Wall St.83d agoneutral
Abbott (ABT) Stock Looks Reasonable On Earnings With Stronger Cash FlowSimply Wall St.83d agoneutral
What Does Abbott Laboratories (ABT) Gain From This New App Controlled Pump Rollout?